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Abstract
Background: Mice harbouring gene mutations that cause phenotypic abnormalities during organogenesis are invaluable
tools for linking gene function to normal development and human disorders. To generate mouse models harbouring novel
alleles that are involved in organogenesis we conducted a phenotype-driven, genome-wide mutagenesis screen in mice
using the mutagen N-ethyl-N-nitrosourea (ENU).
Methodology/Principal Findings: ENU was injected into male C57BL/6 mice and the mutations transmitted through the
germ-line. ENU-induced mutations were bred to homozygosity and G3 embryos screened at embryonic day (E) 13.5 and
E18.5 for abnormalities in limb and craniofacial structures, skin, blood, vasculature, lungs, gut, kidneys, ureters and gonads.
From 52 pedigrees screened 15 were detected with anomalies in one or more of the structures/organs screened. Using
single nucleotide polymorphism (SNP)-based linkage analysis in conjunction with candidate gene or next-generation
sequencing (NGS) we identified novel recessive alleles for Fras1, Ift140 and Lig1.
Conclusions/Significance: In this study we have generated mouse models in which the anomalies closely mimic those seen
in human disorders. The association between novel mutant alleles and phenotypes will lead to a better understanding of
gene function in normal development and establish how their dysfunction causes human anomalies and disease.
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Introduction
Genetic approaches in the mouse have been instrumental in
aiding our understanding of the development, disease and
congenital anomalies of the major organ systems. Most of our
current knowledge has arisen through the use of ‘‘reverse genetic’’
or gene-driven approaches in which the gene of interest is mutated
and the subsequent phenotype analysed. Although reverse genetics
has provided us with a wealth of knowledge it has some limitations.
It requires prior information about the function of the gene to be
altered, is labour intensive, may result in an unexpected phenotype
or no phenotype at all, and can only produce one mouse line at
a time [1].
To circumvent some of these limitations, along with the recent
advances in sequencing technologies, phenotype-driven (forward
genetics) large-scale screens have come back in vogue using the
chemical mutagen N-ethyl-N-nitrosourea (ENU). ENU is efficient
and potent, inducing ,1 mutation per 1–2.7 megabase of the
genome. It creates point mutations, in coding or splice site regions,
in a relatively unbiased fashion. These mutations better reflect the
PLOS ONE | www.plosone.org 1 March 2013 | Volume 8 | Issue 3 | e55429
types of mutations responsible for human disease. ENU can induce
different point mutations within the same gene, thereby creating
an allelic series, each able to reveal a different aspect of the
protein’s function which would not be revealed by a null allele.
ENU injected into male mice introduces mutations into the
genome of all cells including the spermatogonial stem cells
allowing the mutations to be transmitted through the germ-line.
Thousands of genes can be mutated in an efficient manner and
mice screened for phenotypes of interest. Once inheritance of
a phenotype is established the causal gene can be identified using
linkage analysis and sequencing approaches [2,3,4,5,6,7].
Until recently, the bottleneck of ENU mutagenesis has been the
identification of the causal gene. However, recent technological
advancements in mapping and sequencing have made identifica-
tion of the mutant gene more rapid. Typically, gene identification
has previously been reliant on outcrossing the affected male to
a different inbred strain. The progeny are then backcrossed or
intercrossed. The chromosomal region containing the causal gene
can then be identified by linkage analysis. Linkage analysis
technologies are now available in high throughput formats using
mouse strain specific single nucleotide polymorphisms (SNPs).
Once linkage to a chromosomal region is identified candidate gene
sequencing can be carried out. If candidates are not evident then
recent advancements in next-generation sequencing technologies
have made sequencing the exons of hundreds of genes within
a chromosomal region feasible [8,9,10]. Alternatively to chromo-
somal linkage analysis whole exome sequencing may be used to
identify the causal gene and point mutation [7].
Many ENU screening strategies have been employed. These
include region-based screens to identify mutations in a defined
region of the genome [11,12,13,14,15,16,17], sensitized screens
[18,19,20,21] and genome-wide screens [22,23,24,25,26,27].
Many genome-wide, phenotype based screens have been per-
formed to identify both dominant and recessive ENU-induced
mutations. These screens have been extremely successful in
identifying a range of novel alleles important for embryonic
development and disease. Given that many recessive mutations are
lethal it is necessary to perform these screens embryonically.
Genome-wide embryonic recessive screens have focussed on
specific developmental time points and specific phenotypes of
interest [28,29,30,31,32,33,34].
In the present study we performed an ENU mutagenesis screen
in embryonic mice to identify recessive mutations in genes
involved in organogenesis. We brought together a team of
developmental biologists (ENU Organogenesis Consortium), each
with expertise in the development of a specific mouse organ
system. We screened G3 embryos at embryonic day (E) 13.5 and
E18.5 with a focus on identifying phenotypic abnormalities in limb
and craniofacial structures, skin, blood, vasculature, lungs, gut,
kidneys, ureters and gonads. A hierarchical and systematic strategy
was developed in order to screen each of these structures/organs
in every G3 embryo. We identified 15 mutant mouse lines
exhibiting abnormalities in one or more of the structures/organs
screened for and identified novel mutant alleles for Fras1, Ift140
and Lig1.
Results
To screen for recessive mutations a standard three generation
breeding protocol was used (Figure 1). Of the 52 pedigrees
screened 25 were screened at E13.5 only, 14 were screened at
E18.5 only and 13 were screened at both time points. We
identified 15 pedigrees with a reproducible phenotype in multiple
litters (Table 1). Embryos with a range of anomalies were
identified including, structural anomalies (craniofacial, skeletal
and limb defects, exencephaly, spina bifida and curled tail) and
organ anomalies in the kidney, ureter, lung, skin, gonad, eye and
blood. Line 12BCC-22 carried two mutations that resulted in the
segregation of two pedigrees with distinct phenotypes (anaemia
and spina bifida) (Table 1).
A Novel Fras1 Allele Displaying Craniofacial, Skeletal, Skin
and Urinary Tract Anomalies
Line 11BC-5 was originally identified as a strain that exhibited
isolated cleft secondary palate at E18.5. Additional screening
revealed a range of phenotypes including blood filled blisters on
the head and feet at E13.5 and preaxial polydactyly, open eye lids
(Figure 2A–D) and renal agenesis (data not shown) at E18.5. Based
on the phenotype observed in E13.5 embryos, this strain was
named blood filled blisters (bfb). This collection of phenotypic
features is characteristic of the blebs mutants that arise following
mutation of Fras1, Frem 1, 2 and Grip1 [35]. Targeted SNP analysis
using markers polymorphic between C57BL/6 and C3H were
used to investigate the possibility of linkage of the bfb phenotype to
one of these four blebs genes using a cohort of 9 phenotypically
mutant embryos. Markers flanking Frem1, Frem2 and Grip1
exhibited mixed genotypes (Figure 3A). In contrast, markers
flanking Fras1 were homozygous for the C57BL/6 allele in 9/9
samples, indicating clear linkage of the bfb phenotype to Fras1.
Sequencing of all 75 exons and flanking sequences from genomic
DNA of a single mutant identified a 10762T.C substitution (open
reading frame of NCBI RefSeq transcript NM_175473.3) causing
a Ser3588Pro mutation in FRAS1. PolyPhen-2 analysis predicts
that this change is ‘‘probably damaging’’ and SIFT predicts that it
is ‘‘not tolerated’’.
An Ift140 Mutation Resulting in a Complex Ciliopathy
Line 11BC-3 was screened at E13.5 only and exhibits a very
consistent phenotype involving exencephaly, anophthalmia, cra-
niofacial malformation, hindlimb polydactyly and forelimb poly-
and oligodactyly (Figure 2E–G). The hindlimbs were almost
always bilaterally polydactylous while the forelimbs exhibited
roughly equal proportions of oligodactyly, normodactyly and
polydactyly which was uni- or bilateral (Figure 2G). In reference to
the exencephalic morphology, this strain was named cauliflower
(cauli). A significant proportion of E13.5 cauli embryos were in poor
condition and the incidence of embryonic death increased rapidly
with gestational age such that from 22 E17.5–18.5 litters only 7/
137 (5.1%) cauli embryos have been recovered. The poor condition
of many mid-gestation embryos made investigation of laterality
defects impossible but a number of younger embryos have
incidentally been observed to have heart looping defects (not
shown). The impact of these early defects on later cardiac
morphology is yet to be investigated. Conventional SNP-based
linkage analysis identified a 7 Mb interval on chromosome 17
containing 218 genes (Figure 3 B). Given that the cauli mutant
phenotype strongly resembled the phenotype of Ift144 mutants
[36,37] a strong candidate gene within this interval was, Ift140,
a component of the intraflagellar transport complex A (IFT-A) that
regulates retrograde protein transport in ciliated cells [38,39]. A
2564T.A substitution (open reading frame of NCBI RefSeq
transcript NM_134126.3) resulting in an Ile855Lys mutation was
identified in IFT140. PolyPhen-2 indicates that this change is
‘‘possibly damaging’’ while SIFT analysis predicts that it is ‘‘not
tolerated’’.
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Kanyon, a Model of Frontonasal Dysplasia
The 12WT-49 strain phenotype was identified at E13.5 and
presented with defects in the frontonasal process, resulting in a mild
to severe mid-facial cleft, exencephaly and neural tube defects
(Figure 2 H–J). In severe cases the mid- and upper face was
completely cleaved and this strain was therefore named kanyon.
This phenotype is similar to a group of conditions known as
frontonasal dysplasias (OMIM 136760) in which there are deficits
in production of the mid-facial skeleton. Interestingly, the facial
clefting and exencephaly while commonly observed together could
also occur independently. There were no other gross phenotypes
observable. Conventional SNP based mapping identified an
approximately 67 Mb region on chromosome 7 between marker
rs3713432 and rs4226997 containing approximately 1300 genes.
A Mutant Displaying a Link between Holoprosencephaly
and Mandibular Outgrowth
The 12WT-9 strain was identified at E13.5 and presented with
forebrain anomalies, mandibular hypoplasia/aplasia, poorly de-
veloped eyes and hypotelorism (Figure 2 K–M). Given the
combination of small eyes and lower jaw, this strain was named
snoopy, in reference to its resemblance to the cartoon character of
the same name. A small proportion of affected embryos presented
with complete failure of forebrain vesicle separation and cyclopia.
This suggests that the forebrain anomalies and hypotelorism seen
in snoopy are part of a holoprosencephaly spectrum. The aetiology
of the failed mandibular outgrowth is unclear and could be
secondary to cranial neural tube defects. Mandibular hypoplasia/
agnathia is associated with human holoprosencepahly in the
condition agnathia-otocephaly complex (OMIM 202650). A whole
exome sequencing approach is being used to identify the causative
mutation in this strain.
An Isoleucine to Phenylalanine Substitution in DNA
Ligase 1 (Lig1) Results in Anaemia
During early mouse development, embryonic blood is first
produced in the blood islands of the yolk sac (E8.5–E10.5), then
later, during organogenesis (E11.5– E18.5), blood production
switches to the fetal liver in order to meet the increasing needs of
the circulatory and immune systems. At E13.5 haematopoietic
cells constitute at least 50% of the fetal liver and most of these are
haemoglobinised erythroid progenitors. Mutations that completely
block erythropoiesis, such as Gata-1 or Fog-1 null mutations cause
visible anaemia in the liver and circulation by E12.5 and are lethal
between E12.5– E15.5 [40,41].
Based on these criteria we screened embryos for pale livers and
identified E13.5 G3 embryos with visible anaemia in the liver in
line 12BCC-22a (Figure 4A). Giemsa staining of peripheral blood
verified that the embryos lacked mature enucleated red blood cells
(RBC) (Figure 4 B, C). The gene responsible for this blood defect
was localised to a 32.6 Mb region on the proximal end of
chromosome 7 (rs4226386–rs3724525) (Figure 3 C). This region
contained approximately 700 genes. Sequencing of all exons in
this region using NGS identified a 1798A.T substitution in DNA
Figure 1. Breeding strategy for the generation of G3 embryos. C57BL/6J male mice were injected with ENU and bred with females of the
inbred mapping strain, C3H/HeH (C3H). +/+=wildtype, m=mutation, G = generation.
doi:10.1371/journal.pone.0055429.g001
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ligase 1 (Lig1) (open reading frame of NCBI RefSeq transcript
NM_001199310.1) resulting in an Ile600Phe mutation. The
structure of Human LIG1 has been solved and we used this to
predict that Ile 600 is on the surface that contacts DNA during
DNA binding and repair [42]. This mutation alters the charge of
this amino acid in the DNA binding and ATP dependant DNA
ligase domain of LIG1. This may affect the ability of LIG1 to
catalyse the joining of single strand DNA breaks during DNA
replication, repair and recombination.
Line 12BCC-20 Displays Testis Cord Abnormalities
At E11.5, in the mouse, the bipotenital gonad commits to being
either male (testis) or female (ovary) [43]. By E13.5, testes can be
easily distinguished from ovaries by the presence of testis cords and
their bigger size. In this screen we were interested in identifying
mutants in which this decision had been disrupted resulting in an
ovotestis phenotype. In addition, we were interested in mutations
that may disrupt testis size, shape and testis cord formation. In line
12BCC-20, male G3 embryos with smaller testes were identified at
E13.5 (7/36 embryos from affected litters (19.4%)) (Figure 5,
insets). Moreover, while testis cords were clearly visible in
unaffected gonads by gross examination, in affected gonads they
were barely detectable (Figure 5, arrows in insets). Immunofluo-
rescence staining for the Sertoli cell marker, AMH, revealed that
in affected embryos the testis cords were less were less clearly
defined when compared to unaffected embryos (arrows in
Figure 5). The embryos with testis cord abnormalities were
genotyped for chromosomal sex by PCR. All embryos had an XY
karyotype; thus they did not display XX gonadal sex reversal.
Unfortunately, the gonad anomalies were not detected in the
second generation males possibly due to a weakly penetrant
phenotype and the reduced contribution of the C57BL/6 mouse
strain. C57BL/6 mice are exquisitely sensitive to testis de-
velopment defects due to a higher gonadal expression of a female
transcriptome relative to other mouse strains [44].
Lines 12BC-19, 12BC-20 and 14BC-7 Display Kidney and
Ureter Anomalies
Congenital anomalies of the kidney and urinary tract (CAKUT)
commonly arise due to abnormal ureter development as a result of
ectopic or lack of budding of the ureteric bud (presumptive ureter),
ectopic ureter insertion into the bladder, abnormal smooth muscle
cell or urothelium development and obstruction [45]. These
defects, which are more commonly found in baby boys [46,47],
can lead to duplicated ureters, multiple kidneys, renal agenesis,
hypoplasia and vesicoureteral reflux (backflow of urine into the
kidney) causing ureter and renal pelvis dilation and hydrone-
phrosis.
Screening for these various kidney and ureter anomalies
identified three affected lines, 12BC-20, 12BC-19, 14BC-7. In
all lines we found a higher incidence of renal anomalies in males
(82–67%) compared to females (18–33%). Kidneys from males in
line 12BC-20 predominantly displayed dilation of the renal pelvis
and proximal hydroureter either unilaterally (55%, 6/11 affected
Table 1. Summary of ENU-induced mouse mutants.
Line Time-point Phenotype
Affected/Total no.
embryos screened*
Affected/Total no. of
embryos in affected litters Gene ID/mapping
bfb# 18.5 skeletal (craniofacial/polydactyly) 16/149(11%) 9/46(20%) Fras1
skin 5/37 (3.5%)
kidney 2/21 (9.5%)
11BC-11 18.5 Skeletal (syndactyly, craniofacial) 5/116 (4%) 5/20 (25%) Unknown
snoopy# 13.5 craniofacial 8/134 (6%) 8/32 (25%) Unknown
kanyon# 13.5 craniofacial, neural tube,
exencephaly
12/52 (23%) 12/26 (46%) Chr 7
cauli# 13.5 craniofacial, exencephaly, spina
bifida, polydactyly, limb anomalies
15/73 (20.5%) 15/54 (28%) Ift140
12BC-19 18.5 Kidney, ureter 12/208b (6%) 12/64 (18.8%)b unknown
12BC-20 18.5 Kidney, ureter 11/198b (6%) 11/42 (26%)b unknown
12BCC-13 18.5 lung 7/176 (4%) 7/21 (33%) unknowna
12BCC-16 18.5 lung 3/27 (11%) 3/8 (37.5%)$ unknowna
12BCC-20 13.5 gonad 7/280b (2.5%) 7/36 (19%)b unknowna
12BCC22a# 13.5 blood 11/136 (8%) 11/29 (38%) Lig 1
12BCC-22b 13.5 spina bifida, curled tail 23/136 (17%) 23/60 (38%) unknown
12BCC-24 18.5 curled tail 4/24 (17%) 3/15 (20%) unknown
fused digit 1/15 (6.7%)
14BC-2 18.5 eye pigmentation 3/31 (10%) 3/15 (20%) Unknown
14BC-7 18.5 Kidney, ureter 7/305b (2%) 7/43 (16%)b Unknown
#Allele names and symbols have been registered with MGI. Allele ID for Ift140cauli is MGI: 4458412. Mouse strains have been deposited into the Australian Phenome
Bank repository (http://pb.apf.edu.au/phenbank).
*Number of G3 embryos screened in litters with $6 embryos/litter.
$Affected embryos in 3 individual litters. Litter sizes were ,6 embryos for this pedigree.
aThe phenotype was not inherited by the 2nd generation males.
bTotal numbers include male and female. Testis anomalies are only seen in males and kidney anomalies are predominately seen in males. Therefore a greater number of
total embryos were screened.
doi:10.1371/journal.pone.0055429.t001
ENU Mutagenesis in the Mouse
PLOS ONE | www.plosone.org 4 March 2013 | Volume 8 | Issue 3 | e55429
Figure 2. Craniofacial and skeletal mutants. (A–D) 11BC-5 (blood filled blisters; bfb), (E–G) 11BC-3 (cauli), (H–J) 12WT-49 (kanyon), (K–M) 12WT-9
(snoopy). bfb mutant at E13.5 (A) and E18.5 (B–D) exhibiting characteristic haemorrhagic blisters over the eye, side of the head and feet (arrows). The
ENU Mutagenesis in the Mouse
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embryos) or bilaterally (36%, 4/11 affected embryos) (Figure 6 A–
C). Several males had kinked ureters or severely twisted ureters
distal to the dilation (36%, 4/11 affected embryos) (Figure 6 A and
B). Females displayed either bifurcated ureters (9%, 1/11 affected
embryos) (Figure 6 C) or two ureters with one entering the kidney
and the other being blind-ended (9%, 1/11 affected embryos). In
line 12BC-19 the majority of the affected embryos displayed
dilation of the renal pelvis with or without hydroureter and
hydronephrosis (58%, 7/12 affected embryos), 17% (2/12 affected
embryos) displayed ureter duplication and 25% (3/12 affected
embryos) displayed renal agenesis (Figure 6D–F). In line 14BC-7,
43% of the affected embryos displayed dilation of the renal pelvis
(3/7 affected embryos), 43% displayed an alteration in kidney size
or position which is unique to this pedigree (3/7 affected embryos),
7% displayed ureter duplication with hydroureter/hydronephrosis
and 7% displayed unilateral renal agenesis (1/7 affected embryos)
(Figure 6G–I). In all three lines the embryos did not exhibit any
gross non-renal anomalies.
Mutants with Lung Anomalies
Our primary focus for the lung screen was to identify mutants at
E18.5 with thickened lung mesenchyme. The rationale being that
during the late stages of fetal life there is a rapid increase in distal
airspaces in the lung and a thinning of the mesenchyme between
airspaces. These structural changes greatly enhance the gas
exchange potential of the lung in preparation for birth when the
lung must take on the role of gas exchange for the first time
[48,49]. If the lung mesenchyme fails to thin, it impairs gas
exchange after birth and can be fatal in the absence of respiratory
support [50].
To identify lungs with thick lung mesenchyme a histological
screen was undertaken at E18.5 (just prior to birth). We identified
foot blisters can be discrete or distended as in (C) but are typically associated with digit malformations including polydactyly. The blisters over the
eye are commonly associated with open eyelids (D). Cauli embryos at (E) E13.5 and (F) E16.5 present with exencephaly (asterisk) and polydactyly
(arrow). (G) Fore- (FL) and hindlimbs (HL) of an E13.5 cauli embryo illustrating the variable autopod phenotype in the forelimbs. Kanyon embryos (H-J)
frequently present with exencephaly (H, asterisk) and midfacial clefts. Clefts may result from a defect of frontonasal process development such that
the maxillary and frontonasal processes (arrowheads) completely fail to fuse (I) or may present as bilateral cleft lip and palate (J) in mild cases.
Regardless of the severity of the facial cleft, the eyes never develop normally (I, J). Snoopy embryos (K-M) present with forebrain malformation, poor
eye development and mandibular hypoplasia/agnathia (arrow). (L, M) The forebrain often fails to divide into two vesicles (asterisk) and is associated
with various degrees of hypotelorism (M).
doi:10.1371/journal.pone.0055429.g002
Figure 3. Linkage Analysis. (A) Based on the phenotype, a targeted approach was used to establish linkage to Fras1 in the bfb strain. Polymorphic
markers flanking the four previously characterised blebs genes (open boxes) were used to identify a candidate for sequencing. Strong linkage was
observed with the Fras1 gene (grey box). (B) A genome-wide scan established linkage to chromosome 17 in the cauli strain. Chromosome 17-specific
markers were then used to refine linkage to a 7 Mb region between rs3667809 and rs3684506 (grey boxed region) containing 218 genes. No
additional informative markers were available to further refine the linkage region. (C) A genome-wide scan established linkage to chromosome 7 in
the 12BCC-22a line. Subsequent analysis using chromosome 7-specific markers refined linkage to a 32 Mb region containing approximately 700
genes. Numbers to the left in each diagram denote individual mutant embryos except in (C) where both mutant and unaffected embryos are shown.
Black boxes denote homozygous C57BL/6 alleles, grey boxes denote C57BL6/C3H heterozygosity, white boxes denote untested markers.
doi:10.1371/journal.pone.0055429.g003
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two lines 12BCC-013 (7/21 embryos from affected litters, 33%)
and 12BCC-016 (3/8 embryos from affected litters, 37.5%) with
thick, hypercellular lung mesenchyme (Table 1, Figure 7). These
mouse models offered the potential to increase our understanding
of the molecular mechanisms that regulate thinning of the lung
mesenchyme prior to birth. Unfortunately, the thick hypercellular
phenotype was not detected in the second generation mice when
searching for carrier males in line 12BCC-013. This may be due to
a weakly penetrant lung phenotype or the introduction of
a modifier allele that may block the phenotype. Line 12BCC-
016 had to be abandoned as the G1 male mouse failed to produce
further progeny.
Discussion
The genetic insults responsible for many human congenital
defects are yet to be discovered. Generating mouse models of
congenital anomalies provides a valuable resource for understand-
ing the aetiology and molecular mechanisms contributing to such
congenital defects. Using ENU mutagenesis to generate such
mouse models enables novel alleles to be associated with these
conditions as well as providing valuable insights into the control of
normal development. Our phenotype-driven, genome-wide ENU
mutagenesis screen was designed to identify embryonic anomalies
across multiple organs and structures within the same set of
Figure 4. Anaemia in Lig1 mutants. (A) A Lig1 mutant (mut) with pale orange liver (arrow) compared to the red haemoglobin rich liver of
a wildtype (wt) littermate. (B, C) Analysis of peripheral blood in E13.5 embryos by cytospin and Giemsa staining (x40). (B) Lig1 mutant (mut) peripheral
blood shows a high proportion of nucleated erythroblasts (arrow) to enucleated erythroblasts (arrowhead) compared with (C) a wild type (wt)
littermate.
doi:10.1371/journal.pone.0055429.g004
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embryos. In addition, we successfully established a hierarchical
and systematic protocol that could be used for future high
throughput multi-organ screens. We generated ENU-induced
mouse models that displayed craniofacial, skeletal, kidney, ureter,
lung, skin, haematological and gonadal anomalies and have
identified several novel alleles associated with some of these
anomalies.
Figure 5. Testis cord defects in line 12BCC-20 at E13.5. Immunofluorescence staining for the Sertoli cell marker AMH (red, cytoplasm) on testis
sections from unaffected (XY control) and affected (XY mutant) embryos. In affected embryos, testis cords are less organized when compared to
unaffected embryos. Insets: Gross-examination of testes from unaffected and affected embryos. In affected embryos, testes are smaller and testis
cords are barely detectable. Arrows indicate testis cords. All scale bars are 50 mm.
doi:10.1371/journal.pone.0055429.g005
ENU Mutagenesis in the Mouse
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Figure 6. Urinary tract anomalies displayed by lines 12BC-19, 12BC-20 and 14BC-07. 12BC-20 (A–C) (A) Unilateral and (B) bilateral dilation
of the renal pelvis (*). Kinks (A) and twisting (B) of the ureter (arrow) distal to the dilation. (C) Ureter bifurcation at the site marked with a line. Single
ureter (arrow) below and bifurcated ureter (arrows) above the line. 12BC-19 (D–F) (D) Unilateral renal agenesis. (E) Bilateral hydronephrosis. (F)
Bilateral hydroureter and hydronephrosis. 14BC-07 (G–I) (G) Dilated renal pelvis (*). (H) Duplicated ureter with hydroureter in one ureter leading to
hydronephrosis in upper pole. (I) Unilateral renal hypoplasia (lines marking top and bottom of kidneys). a = adrenal, u = ureter.
doi:10.1371/journal.pone.0055429.g006
ENU Mutagenesis in the Mouse
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The most common anomalies identified in this screen involved
structural defects (craniofacial, skeletal, limb and neural tube
defects). Craniofacial anomalies comprise one third of all human
birth defects and have a prevalence of 1% of live births worldwide
[51]. Several pedigrees in this study displayed craniofacial
anomalies. In particular, the kanyon and snoopy mutants
exhibited phenotypes that mimic those seen in the human
conditions, frontonasal dysplasias (OMIM 136760) and agnathia-
otocephaly complex (OMIM 202650), respectively. Further
characterisation of the kanyon and snoopy strains and the genetic
mutation underpinning them will provide valuable information on
the aetiology of similar conditions in humans.
Several mutants with defects in limb/digit formation were
identified in this screen. Of particular interest was the cauli mutant
which predominantly displayed exencephaly and polydactyly and
is highly reminiscent of the phenotype seen in a number of sonic
hedgehog (Shh) signalling pathway mutants [52,53,54]. The
similarity of the cauli phenotype to existing Shh pathway mutant
models provided very strong support for selecting Ift140 as
a candidate for sequencing. IFT140 is a core component of the
retrograde intraflagella transport mechanism and is therefore a key
component of the signalling nexus operating within the primary
cilium [38,39]. Further studies are required to determine the role
Ift140 plays in limb/digit formation. Mutations in IFT140 have
recently been identified in Mainzer-Saldino syndrome (OMIM
266920) [55] further expanding the rapidly growing collection of
human disorders caused by defects in primary cilia function.
The bfb mutant is an excellent example of a mouse model with
multiple anomalies that were of interest to several investigators
involved in this screen. The anomalies included blood filled
blisters, isolated cleft palate, open eyelids, polydactyly and urinary
tract defects. Fluid-filled or haemorrhagic blisters are the classic
phenotype of the blebs mutant mice [35]. The first blebs mutant
gene identified was Fras1 [56,57] and each of the subsequently
identified blebs mutations are in genes encoding structurally or
functionally related proteins [35]. Mutation of FRAS1 in humans
causes Fraser Syndrome which involves a series of related
phenotypes to the blebs mutants [35]. The Fras1 mutation
identified in the bfb mutant occurs within a structurally unchar-
acterised domain between the CALXb (calcium binding) domains
and the transmembrane domain. The impact of this novel
mutation on FRAS1 function is unclear but given the similarity
of the bfb and Fras1 null mice, it seems likely that the bfb mutation
severely compromises FRAS1 function during early embryonic
development.
The Lig1 mutant displayed a heritable recessive anaemic
phenotype characterised by a pale liver and reduced circulating
blood. The anaemic phenotype of the homozygous Lig1 mutants
was associated with a relative decrease in mature RBCs and
increased numbers of primitive, nucleated erythrocytes in circu-
lating blood. This is consistent with the phenotype of the Lig1 null
mutant mice described by Bentley et al., (1996) [58]. Interestingly,
a human compound heterozygote carrying two mutated LIG1
alleles (Glu566Lys and Arg771Trp) has been described [59]. This
patient displayed symptoms similar to Bloom syndrome, including
Figure 7. Lung anomalies displayed by lines 12BCC-013 and 12BCC-016. Lung histology in line 12BCC-013 (A, B) and 12BCC-016 (C, D).
Affected lungs in lines 12BCC-013 (B) and 12BCC-016 (D) both displayed hypercellular, thickened lung mesenchyme (m) which can be clearly seen by
the increased pink/purple staining of cells and their nuclei, between the small airways (a) in B and D compared to that in the lungs of unaffected
littermate embryos (A and C), respectively.
doi:10.1371/journal.pone.0055429.g007
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immunodeficiency and increased cellular sensitivity to DNA-
damaging agents, culminating in lethal lymphoma at age 19 [60].
Further analysis of our Lig1 mutant may reveal the molecular role
that this gene plays in erythropoiesis and carcinogenesis.
We identified several pedigrees with urinary tract abnormalities
with the most common anomalies being dilation of the renal pelvis
and/or ureter and hydronephrosis. Three of these mutants
presented with non-syndromic renal and ureter anomalies and
the Fras1 mutant represented renal anomalies associated with
a syndrome. These ENU mouse models are invaluable in studying
the aetiology of the human condition CAKUT [61], which
accounts for one-third of the anomalies detected by fetal
ultrasound and can lead to end stage renal disease [62]. Whole
exome sequencing is underway to identify the causal genes which
will serve as candidate CAKUT genes for genetic screening of
patients.
We have demonstrated that a multiple organ screen in
embryonic mice performed remotely (The Australian Phenomics
Facility, Canberra) to the multi-site investigators is highly feasible.
In this screen, embryonic dissections were performed in a hierar-
chical and systematic manner (see Method S1), the technician was
trained by the expert investigators to dissect and observe specific
anomalies in the organs of interest. Phenotypes were recorded
using digital photography and entered into the web-based,
password protected database allowing all multi-site investigators
to visualise phenotypes immediately. Organs and embryos were
fixed and sent to the expert investigators for further analysis. The
protocol we have described in detail (Method S1) forms the basis
for establishing high throughput lethal screens in the future. The
phenotyping protocol we outline in this report could be applicable
to screening large numbers of embryonic lethal lines generated not
only by ENU but also by gene targeting and gene trapping as is
being undertaken by The International Knockout Mouse Con-
sortium (IKMC). In many respects the throughput of our screen
(more than 50 lines over a 2 year period) was limited not by the
ability to undertake the phenotyping, but rather the generation of
the ENU mutagenised pedigrees. We propose that the phenotyp-
ing protocol we describe would be easily applied to the analysis of
50–100 lines per year. Clearly this approach is not applicable to
the average independent laboratory but our forecast throughput is
well within the scope of existing and proposed high throughput
lethal screens, including those encompassed and envisaged by the
International Mouse Phenotyping Consortium (http://www.
mousephenotype.org/) and the KOMP2 funding initiative
(http://commonfund.nih.gov/KOMP2/). In addition, screening
the same set of embryos for multiple organ anomalies provides
a more comprehensive analysis of the mutant, allows the
investigator to determine if they are dealing with a syndromic
(as was the case with the Fras1 mutant) or non-syndromic (isolated
organ anomaly) condition, is more cost effective and facilitates
teamwork and collaboration.
During the time in which this screen took place there were rapid
advancements in new sequencing technologies. These new
technologies have subsequently superseded the need to outcross
mice to an inbred strain to perform recombination mapping. For
the initial mutants identified in our screen, low-resolution genome
mapping was performed using SNP genotyping to identify
chromosomal linkage. In the case of line 12BCC-22a, linkage to
an interval on Chr 7 was identified which contained over 700
genes. Next Generation Sequencing (NGS) eliminated the need to
perform further breeding, which would have been required for
recombination mapping and narrowing of the interval within
which to select candidates for Sanger sequencing. NGS was used
to sequence all exons in this interval leading to the identification of
Lig1 as the causal gene. For those mutants of interest, for which the
causal genes are yet to be identified in this screen, chromosome
specific or whole exome sequencing is being employed. Exome
sequencing on average covers .95% of the consensus coding
sequence (CCDS) exome [63]. Although mutations in non-coding
regions are not isolated using exome sequencing, 99% of ENU
mutations occur in splice sites and exons therefore exome
sequencing should identify almost all ENU-induced mutations
[7]. There will be some situations where mutations will be missed
as a result of capture baits not covering specific genomic regions,
the gene not being annotated as part of the CCDS, fragment mis-
mapping or bad sequence coverage/quality due to high/low GC
content [7,64]. Despite these limitations gene mapping will be
phased-out of future ENU-based screens and replaced with whole
exome sequencing [7,64]. Unlike recombination mapping, in
which many affected and unaffected embryos are required to
identify the mutated gene, exome sequencing initially only requires
one affected embryo to identify the candidate casual mutation.
ENU induced single nucleotide variations (SNVs) can then be
subsequently validated in a larger cohort of embryos taking
advantage of heritability information. This will rapidly reduce the
time spent trying to identify the causative gene and allow mouse
genotyping to be established earlier thereby reducing mouse
husbandry costs. This will also undoubtedly decrease the
percentage of valuable lines that are abandoned as a result of
loss of phenotype during carrier searches and establishing
heritability, as was the case in lines 12BCC-13 (lung anomalies)
and 12BCC-20 (gonadal anomalies) in this study.
The efficiency of our screen at day E13.5 was 16% and at E18.5
was 33%. Many previous screens that have used ENU to identify
genes that play a role during embryogenesis have focussed on
earlier embryonic processes such as patterning and morphogen-
esis, often examining embryos at E9.5–10.5 [28,65,30,66,31,32],
or screening for post-natal lethality [11,17,67] and are therefore
not directly comparable with our study. Additionally, some screens
focused on mid-late gestation time-points but are not directly
comparable because they used imaging techniques (rather than
dissection) to reveal phenotypes [33,68]. The recovery rate of
mutations in our E13.5 screen was similar (but lower) to that of
Ermakov et al [34] whom reported that 24% of pedigrees
examined at E13.5 had consistent mutant phenotypes in two or
more embryos, and our E18.5 screen was similar (but higher) to
the 29% of phenotype containing pedigrees identified by dissection
of E18.5 embryos by Herron et al [29]. Overall, the recovery rate
reported in our study is similar to those previously reported in
comparable screens.
Unfortunately, in our screen we did not recover a mutant
displaying a gut phenotype. Our objective was to identify key
regional gut patterning defects at E13.5 and gut epithelial defects
at E18.5. The initial screening was based on identifying overall
changes in morphology, length and diameter of the gastrointestinal
tract in wholemounts. Although several embryos were highlighted
for further examination after superficial examination, no overt
anomalies were detected by histology. This indicates that
attempting to screen for cellular defects based on overall
morphology is not an effective method for identifying intestinal
mutants. A more definitive method would be a screen based on
histological criteria as was performed for the lung screen. Although
feasible this is extremely labour intensive.
Conclusions
In this study we have generated ENU-induced mutant mice that
model human genetic disorders. We have identified novel mutant
alleles of known genes which promise to provide further insight
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into the function of these genes. Despite several other ENU
mutagenesis screens designed to identify recessive mutations that
affect embryogenesis, the genes mutated in our screen have not
been previously identified in these screens. This demonstrates the
high potential for the discovery of novel alleles from such screens.
The associations between phenotype and genotype which can be
identified without prior gene bias, using ENU mutagenesis are
invaluable in providing insight into the mechanisms that underlie
normal development and human congenital disease.
Methods
ENU-mutagenesis
Animal experiments were conducted with approval of the
Australian National University Animal Experimentation Ethics
Committee and carried out in accordance with institutional
guidelines. Male C57BL/6J mice were given three weekly
intraperitoneal injections of 90 mg ENU/kg body weight as
described previously [69]. After an 8 week recovery period the
ENU treated male mice (G0) were crossed with either C57BL/6 or
C3H/HeH (C3H) females to generate 89 founder males (F1). To
screen for recessive mutations a standard three generation
breeding protocol was used (Figure 1). F1 males which were
heterozygous for the ENU induced mutations were crossed to
C57BL/6J or C3H females to generate G2 progeny. The G2
daughters, half of which were heterozygous for the mutations,
were backcrossed to their F1 fathers to generate G3 embryos that
were screened at E13.5 and/or E18.5 for anomalies in skin, lung,
kidney, ureter, vasculature, blood, gut, gonad and limb/craniofa-
cial structures. Biopsies were taken from the embryos or yolk sacs
for DNA extraction. A minimum of 4 litters were screened
(average litter size 6–8 embryos and a minimum of 24 embryos)
per pedigree and time-point. 12.5% of the G3 embryos were
expected to be homozygous for the mutations. 52 lines were
screened to completion with 37 additional lines abandoned due to
breeding issues and small litter sizes.
Screen
G3 embryos were examined for gross external visible anomalies
of the skin, limb and craniofacial structures, haemorrhages,
oedema (vascular abnormalities) and anaemia (blood abnormali-
ties). Embryos were then dissected and lungs, gut, kidneys, ureters
and gonads were microscopically examined. Blood, vascular and
gonadal anomalies were examined microscopically at E13.5 only.
Gonads were screened for ovotestes and abnormalities in testis
cord formation (eg smaller gonads, fewer or disorganised cords).
Lungs were examined histologically at E18.5 only. Skin, limb/
craniofacial structures, kidneys, ureters and gut were examined at
both time points. Anomalies were recorded using digital photog-
raphy. Results and photographs were entered in a web-based,
password-protected, in-house database, Musterer. All carcasses
and organs were fixed in 10% formalin. A full description of the
screening protocol is provided in the Supplementary Information
(Method S1).
Sex Genotyping of Mouse Embryos
Embryos were sexed by PCR using primers based on the mouse
Smcx and Smcy genes as previously described [70]. Genomic DNA
was isolated from the yolk sacs of embryos exhibiting testis
anomalies for sex genotyping.
Histology
All fixed E18.5 lungs were embedded in paraffin and 5 mm
sections were stained with haematoxylin and eosin. Sections were
examined for defects in distal lung development including
condensed (thickened) lung mesenchyme, dilated distal airspaces,
overt defects in vascular development and abnormal progression
from pseudostratified columnar epithelial cells lining proximal
airspaces to cuboidal/squamous epithelial cells lining the distal
airspaces.
Blood Analysis
Cytospins were performed on whole blood at 5006g for
4 minutes in a Cytospin 3 (Shandon). Cells were fixed in 100%
methanol and stained with May-Grunwald-Giemsa.
DNA Isolation
DNA was extracted from embryonic tissue using proteinase K
digestion and precipitation. Approximately 50 mg of tissue was
lysed at 55uC for 4 hours in 500 ml buffer containing 50 mM
Tris.HCl, pH 8 (Sigma), 100 mM EDTA (Sigma), 0.5% SDS
(Sigma) and 200 mg/ml proteinase K (Bioline). Following centri-
fugation at 180006g for 10 min the supernatant was mixed with
150 ml 5 M NaCl (Sigma) and incubated at room temperature for
10 min. The supernatant from a second centrifugation (as
previously) was mixed with 450 ml ice-cold isopropanol. The
DNA was pelleted by a third centrifugation step and washed twice
in 100 ml 70% ethanol prior to drying and resuspending in 100 ml
of Tris.HCl buffered water. The quality and concentration of the
DNA was determined by spectrophotometer absorbance readings
at 260, 280 and 230 nm, followed by agarose gel electrophoresis
analysis.
Mapping
For linkage analysis genomic DNA from approximately 10–20
affected and 10–20 unaffected G3 C57BL/6J6C3H mice were
screened with 41 strain specific SNP markers at proximal, distal
and central positions on each chromosome using the Amplifluor
SNP genotyping system (Chemicon, Millipore). Additional SNP
markers were used within linked regions to further fine map the
causal mutation in each strain.
Sequencing
Sequencing of candidate genes was performed to locate the
causal base substitution. DNA was prepared from an individual
affected mouse. Primers were designed for candidate genes to
amplify all exons +/215 bp to cover splice junctions. Amplicons
were then Sanger sequenced on an Applied Biosystems 3730xl
capillary sequencer. This automated platform uses Big Dye
Terminator (BDT) chemistry version 3.1 (Applied Biosystems).
The raw trace files were analysed using Lasergene software
(DNAstar) against the C57BL/6J mouse reference genome (mm9/
NCBI m37).
Next Generation Sequencing
A SureSelect custom solution array (Agilent) was designed using
the online tool, eArray to include Refseq release 43 (NCBI)
annotated exons (plus splice donor and acceptor sites) within the
linkage interval. 100 bp paired end Illumina libraries of the
captured regions from a single affected mouse were produced and
run in a single lane of an Illumina GAIIx. Sequence reads were
mapped to the NCBIM37 assembly of the reference mouse
genome using the bowtie aligner47. Untrimmed reads were
aligned allowing a maximum of two sequence mismatches and
were discarded where they aligned to the genome more than once.
Sequence variants were identified with SAMtools and custom perl
scripts were subsequently used to identify those which occurred
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within exons and splice donor/acceptor sites, and were not known
or strain-specific variants.
Mutation Validation
Single nucleotide variations (SNVs) identified by Sanger or Next
Generation Sequencing were validated using the Amplifluor SNP
genotyping system (Chemicon, Millipore). Assays were designed to
each SNV of interest and validated against a set of embryos
affected for the phenotype of interest and a set of unaffected
embryos. Amplifluor validation primers for Fras1, Ift140 and Lig1
are listed in Table S1. For the bfb line 39 embryos (26 unaffected
and 13 affected), for the cauli line 37 embryos (29 unaffected and 8
affected) and for the Lig1 line 20 embryos (10 affected and 10
unaffected) were genotyped to confirm the association of genotype
to phenotype. In all cases the genotype correlated with the
phenotype.
Immunofluorescence
Testes were fixed, processed and sectioned as described
previously [71]. For indirect immunofluorescence staining, frozen
sections were incubated with Anti-AMH goat polyclonal antibody
(1:200; Santa Cruz, sc-6886) followed by detection with an Alexa
dye-linked secondary antibody (1:1000; Molecular Probes). Images
were captured using fluorescence microscopy (Olympus Corp.,
NY, USA).
Supporting Information
Table S1 Amplifluor Genotyping Primers.
(DOC)
Method S1 ENU Organogenesis Screening Protocol.
(DOC)
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